Sandy Hook, CT, United States of America

Derek Cogan

This inventor holds 24 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Cytokine Inhibitors. Top assignees: Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim International Gmbh, Volastra Therapeutics, Inc.. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek Cogan. Retrieved from https://idiyas.com/inventor/derek-cogan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 111(Granted Patents)

Location History:

Sandy Hook, CT (US) (2007 - 2015)
Ridgefield, CT (US) (2016 - 2018)
Boston, MA (US) (2020)
New York, NY (US) (2023 - 2024)

Company Filing History:

11 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

10 out of 1,562

Boehringer Ingelheim International Gmbh

patents

3 out of 3

Volastra Therapeutics, Inc.

patents

4. 1 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

Areas of Expertise:

Cytokine Inhibitors

Aldosterone Synthase

Heterocyclic Compounds

Indoline Compounds

Cathepsin-S

KIF18A

Imidazole Derivatives

PKC-Theta

5-HT2B Receptor

Pyrimidine Derivatives

Anti-Cytokine

Triazole Compounds

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12091412 - Heterocyclic inhibitors of ENPP1 (2024-09-17),

2. 12084420 - Indoline compounds for inhibiting KIF18A (2024-09-10),

3. 11780849 - Imino sulfanone inhibitors of ENPP1 (2023-10-10),

4. 10858342 - Bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases and fibrotic diseases (2020-12-08),

5. 10131642 - Aldosterone synthase inhibitors (2018-11-20),

6. 9890171 - Aldosterone synthase inhibitors (2018-02-13),

7. 9334285 - Aldosterone synthase inhibitors (2016-05-10),

8. 9181272 - Aldosterone synthase inhibitors (2015-11-10),

9. 8859814 - [object Object] (2014-10-14),

10. 8729114 - Heteroaryl nitrile compounds useful as inhibitors of Cathepsin-S (2014-05-20),

11. 8609696 - Serotonin 5-HT2B receptor inhibitors (2013-12-17),

12. 8586748 - 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 (2013-11-19),

13. 8552205 - Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides (2013-10-08),

14. 7790712 - Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors (2010-09-07),

15. 7592332 - Cytokine inhibitors (2009-09-22),

Title: The Innovative Journey of Derek Cogan

Introduction: Derek Cogan, a talented inventor hailing from Sandy Hook, CT (US), has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Derek Cogan's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: With a background in engineering and a passion for innovation, Derek Cogan has successfully brought several inventions from concept to market, earning him recognition as a leading figure in the field of technology.

Collaborations: Throughout his career, Derek Cogan has collaborated with top research institutions and leading tech companies to further develop his inventions and bring them to a wider audience. His collaborative efforts have resulted in the successful commercialization of several groundbreaking products.

Conclusion: Derek Cogan's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the world of technology continue to inspire and shape the future of innovation.

Profile summary based on public USPTO records.